![The Lancet Oncology in conversation with artwork](https://is1-ssl.mzstatic.com/image/thumb/Podcasts125/v4/4e/3e/ef/4e3eefcf-c4c6-a704-062b-d40be7b03ea7/mza_5325872108990078460.jpg/100x100bb.jpg)
Indel derived tumour-specific neoantigens: The Lancet Oncology: Aug 2017
The Lancet Oncology in conversation with
English - July 26, 2017 15:00 - 8 minutes - 5.56 MB - ★★★★★ - 1 ratingMedicine Health & Fitness Education cancer radiotherapy chemotherapy mrna Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Prior radiotherapy and pembrolizumab: The Lancet Oncology: June 28, 2017
Samra Turajlic discusses the contribution of small insertions and deletions to tumour-specific antigen analyses.
Tell us what you thought about this episode
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv